Johnson & Johnson (JNJ) stock
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3086% above fair value
$278.70−3.85 (-1.36%)
Close on Nov 17, 2026Market cap $670.92BP/E 42.3Yield 1.84%
Johnson & Johnson profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Johnson & Johnson's profit margin for the twelve months ending Sep 27, 2026 was 16.2%. For fiscal 2025 it was 28.5%, against 15.8% the year before. The highest annual figure on record is 41.3% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | 28.5% | +12.6 |
| FY2024 | Dec 29, 2024 | 15.8% | −25.4 |
| FY2023 | Dec 31, 2023 | 41.3% | +18.9 |
| FY2022 | Jan 1, 2023 | 22.4% | −4.1 |
| FY2021 | Jan 2, 2022 | 26.5% | +8.7 |
| FY2020 | Jan 3, 2021 | 17.8% | −0.6 |
| FY2019 | Dec 29, 2019 | 18.4% | −0.3 |
| FY2018 | Dec 30, 2018 | 18.8% | +17.1 |
| FY2017 | Dec 31, 2017 | 1.7% | −21.3 |
| FY2016 | Jan 1, 2017 | 23.0% | +1.0 |
| FY2015 | Jan 3, 2016 | 22.0% | +0.0 |
| FY2014 | Dec 28, 2014 | 22.0% | +2.6 |
| FY2013 | Dec 29, 2013 | 19.4% | +3.3 |
| FY2012 | Dec 30, 2012 | 16.1% | +1.3 |
| FY2011 | Jan 1, 2012 | 14.9% | −6.8 |
| FY2010 | Jan 2, 2011 | 21.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 27, 2026 | 0.8% | −20.6 |
| Q2 FY2026 | Jun 28, 2026 | 21.9% | −1.5 |
| Q1 FY2026 | Mar 29, 2026 | 21.8% | −28.5 |
| Q4 FY2025 | Dec 28, 2025 | 20.8% | +5.6 |
| Q3 FY2025 | Sep 28, 2025 | 21.5% | +9.5 |
| Q2 FY2025 | Jun 29, 2025 | 23.3% | +2.4 |
| Q1 FY2025 | Mar 30, 2025 | 50.2% | +35.0 |
| Q4 FY2024 | Dec 29, 2024 | 15.2% | −3.7 |
| Q3 FY2024 | Sep 29, 2024 | 12.0% | −109.9 |
| Q2 FY2024 | Jun 30, 2024 | 20.9% | −3.0 |
| Q1 FY2024 | Mar 31, 2024 | 15.2% | +15.5 |
| Q4 FY2023 | Dec 31, 2023 | 18.9% | +1.3 |
| Q3 FY2023 | Oct 1, 2023 | 121.9% | +99.6 |
| Q2 FY2023 | Jul 2, 2023 | 23.9% | +0.1 |
| Q1 FY2023 | Apr 2, 2023 | -0.3% | −26.3 |
| Q4 FY2022 | Jan 1, 2023 | 17.7% | −30.8 |
| Q3 FY2022 | Oct 2, 2022 | 22.3% | +6.6 |
| Q2 FY2022 | Jul 3, 2022 | 23.8% | −3.1 |
| Q1 FY2022 | Apr 3, 2022 | 26.0% | −1.8 |
| Q4 FY2021 | Jan 2, 2022 | 48.5% | +40.7 |
| Q3 FY2021 | Oct 3, 2021 | 15.7% | −1.1 |
| Q2 FY2021 | Jul 4, 2021 | 26.9% | +7.2 |
| Q1 FY2021 | Apr 4, 2021 | 27.8% | −0.2 |
| Q4 FY2020 | Jan 3, 2021 | 7.7% | −11.6 |
| Q3 FY2020 | Sep 27, 2020 | 16.9% | +8.4 |
| Q2 FY2020 | Jun 28, 2020 | 19.8% | −7.5 |
| Q1 FY2020 | Mar 29, 2020 | 28.0% | +9.3 |
| Q4 FY2019 | Dec 29, 2019 | 19.3% | +4.4 |
| Q3 FY2019 | Sep 29, 2019 | 8.5% | −10.9 |
| Q2 FY2019 | Jun 30, 2019 | 27.3% | +8.3 |
| Q1 FY2019 | Mar 31, 2019 | 18.7% | −3.1 |
| Q4 FY2018 | Dec 30, 2018 | 14.9% | +68.0 |
| Q3 FY2018 | Sep 30, 2018 | 19.3% | +0.2 |
| Q2 FY2018 | Jul 1, 2018 | 19.0% | −1.3 |
| Q1 FY2018 | Apr 1, 2018 | 21.8% | −3.1 |
| Q4 FY2017 | Dec 31, 2017 | -53.0% | −74.1 |
| Q3 FY2017 | Oct 1, 2017 | 19.2% | – |
| Q2 FY2017 | Jul 2, 2017 | 20.3% | – |
| Q1 FY2017 | Apr 2, 2017 | 24.9% | – |
| Q4 FY2016 | Jan 1, 2017 | 21.1% | – |
See a number that looks wrong?